We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPOK:NASDAQSpok Holdings, Inc. Analysis

Data as of 2026-05-02 - not real-time

$10.54

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Spok Holdings is trading well below its 200‑day moving average, with the 20‑day SMA under the 50‑day SMA, confirming a bearish price trend. The MACD line sits beneath its signal line, and the histogram is negative, reinforcing downside momentum. The RSI is in the low‑30s, hinting at oversold conditions but not yet a clear reversal signal. At a market price of roughly $10.5, the stock is priced beneath the DCF‑derived fair value of $13.2, suggesting a material upside potential. The forward P/E of about 12x is well under the industry average of 25x, further underscoring relative cheapness. However, the company’s revenue contracted by 8.5% year‑over‑year and the payout ratio exceeds 200%, raising concerns about dividend sustainability. Recent news highlights a strategic cost‑cutting plan aimed at improving profitability, which could help stabilize margins. The dividend yield remains exceptionally high at nearly 12%, but the unsustainable payout ratio implies possible future cuts. Volatility over the past month exceeds 25% while beta is modest at 0.43, indicating the stock can swing sharply but is less correlated with the broader market. Overall, the combination of undervaluation, high dividend yield, and ongoing restructuring creates a nuanced picture: upside is plausible if the turnaround succeeds, yet short‑term risk remains elevated.
The firm’s cash position comfortably exceeds its debt, and free cash flow is positive, supporting continued operations. Return on equity and assets are modest, reflecting the recent revenue decline. The sector—health information services—carries medium regulatory exposure, and the company’s global footprint adds a moderate geographic risk. Liquidity appears adequate with stable volume, but the modest market cap keeps the stock susceptible to larger price moves. Investors should weigh the attractive valuation against the bearish technical setup and dividend sustainability issues when forming a view.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below SMA, negative MACD)
  • Current price near support with limited upside
  • Unsustainable dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued relative to DCF and industry multiples
  • Cost‑reduction initiatives aimed at margin improvement
  • High dividend yield but risk of reduction

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential upside from strategic realignment and cash‑flow generation
  • Low beta offering defensive characteristics
  • Sector tailwinds in digital health communications

Key Metrics & Analysis

Financial Health

Revenue Growth-8.50%
Profit Margin9.27%
P/E Ratio17.9
ROE8.66%
ROA5.29%
Debt/Equity4.41
P/B Ratio1.5
Op. Cash Flow$29.1M
Free Cash Flow$19.8M
Industry P/E25.6

Technical Analysis

TrendBearish
RSI31.4
Support$9.95
Resistance$11.67
MA 20$11.19
MA 50$11.63
MA 200$14.36
MACDBearish
VolumeStable
Fear & Greed Index91.09

Valuation

Fair Value$13.23
Target Price$14.00
Upside/Downside32.83%
GradeUndervalued
TypeValue
Dividend Yield11.86%

Risk Assessment

Beta0.43
Volatility25.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.